Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

FDA clears first ACL reconstruction device for use in paediatric patients

January 11, 2023 Medical Communications

The FDA has cleared the ACL TightRope® II implant to treat torn knee ligaments in children and adolescents. The implant …
News

BioNTech acquires AI company InstaDeep for £562m

January 11, 2023 Medical Communications

Germany-based BioNTech has acquired UK AI start up InstaDeep for £562m after a multi-year partnership. The acquisition is part of …
News

Insilico Medicine shares positive topline results of phase 1 trial of AI-designed drug for AI-discovered target

January 10, 2023 Medical Communications

Clinical stage AI-driven drug R&D company, Insilico Medicine, has announced positive topline results from its phase 1 trial assessing the …
News

FDA issues Emergency Use Authorisation for BD and CerTest Biotec’s Monkeypox PCR test

January 10, 2023 Medical Communications

US medical technology company BD and Spanish biotechnology company CerTest Biotec have joined forces to develop a real-time Monkeypox test …
News

NHS to offer artificial pancreas to type 1 diabetes patients

January 10, 2023 Medical Communications

The NHS will soon be offering an artificial pancreas to more than 100,000 people with type 1 diabetes across England …
News

BioNTech and UK Government announce strategic partnership to provide mRNA cancer immunotherapies

January 6, 2023 Medical Communications

German biotech company BioNTech and the UK Government have signed a Memorandum of Understanding (MoU) which will accelerate clinical trials …
News

Withings announces hands-free connected in-home urine lab

January 6, 2023 Medical Communications

Connected health firm Withings has unveiled its new in-home biomarker analysis platform U-Scan. It is hoped the device will utilise …
News

Synaffix Enters License Agreement with Amgen to Build Next Generation ADCs

January 5, 2023 Medical Communications

AMSTERDAM, THE NETHERLANDS, 5 January 2023 — Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology for …
News
Press release

FDA accepts application for nirsevimab as first protective option for RSV in infants

January 5, 2023 Medical Communications

The FDA has accepted an application for nirsevimab as the first protective option to combat respiratory syncytial virus (RSV) disease …
News

FDA expands access to abortion pills

January 4, 2023 Medical Communications

Following new rules from the FDA under the Biden administration, patients can now obtain the abortion pill mifepristone from retail …
News

Novartis pays $245m to settle Exforge generic pay-for-delay lawsuit

January 4, 2023 Medical Communications

Swiss pharma company Novartis will settle a classic generic pay-for-delay legal battle with direct purchasers, indirect purchasers and retailers regarding …
News

FDA grants Breakthrough Device Designation for Burning Rock’s multi-cancer detecting test

January 4, 2023 Medical Communications

Burning Rock, a Chinese biotech company which focuses on the applications of next-generation sequencing (NGS) technology in the field of …
News

FDA expected to make decision on controversial Alzheimer’s drug this week

January 4, 2023 Medical Communications

The FDA are expected to come to a decision on Eisai and Biogen’s Alzheimer’s drug lecanemab by the end of …
News

MediWound receives FDA approval for NexoBrid

January 3, 2023 Medical Communications

Israeli biopharma company MediWound has secured FDA approval for its wound care product NexoBrid (anacaulase-bcdb). US-based biopharma company Vericel will …
News

Datar blood test receives FDA Breakthrough Designation

January 3, 2023 Medical Communications

Datar Cancer Genetics has secured FDA Breakthrough Designation for their blood test used to detect inaccessible brain tumours, where traditional …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026